Liwang Lin
23 You Zheng Street
Harbin, 150001, China
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Gut microbiota-derived indole-3-propionic acid attenuates Arsenic trioxide-induced cognitive impairment by inhibiting ubiquitination and degradation of BRD4.
Journal: British journal of pharmacology
Published: February 28, 2026
Involvement of trimethylamine N-oxide in major depressive disorder via astrocytic d-Serine dysregulation.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 27, 2025
Administering Bifidobacterium pseudolongum With Arsenic Trioxide Attenuates Acute Promyelocytic Leukemia in Mice by Restoring Immune Microenvironment and Intestinal Homeostasis.
Journal: Frontiers in bioscience (Landmark edition)
Published: November 26, 2025
Involvement of TMAO in exacerbating arsenic-induced neurotoxicity by activating the PERK/eIF2α/ATF4 pathway.
Journal: Ecotoxicology and environmental safety
Published: January 18, 2025
Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
Journal: Toxicology letters
Published: July 13, 2022
Sacubitril/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro.
Journal: Toxicology research
Published: July 05, 2022
Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange.
Journal: Journal of clinical pharmacy and therapeutics
Published: February 07, 2022
Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
Journal: Expert review of clinical pharmacology
Published: June 28, 2021
Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 11, 2021
Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
Journal: Expert review of clinical pharmacology
Published: March 08, 2021
Pharmacokinetic Characteristics, Tissue Bioaccumulation and Toxicity Profiles of Oral Arsenic Trioxide in Rats: Implications for the Treatment and Risk Assessment of Acute Promyelocytic Leukemia.
Journal: Frontiers in pharmacology
Published: December 30, 2020
Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
Journal: Toxicology letters
Published: November 05, 2020
Last Updated: 09/26/2026